Abstract
Objective
Image-guided sternal biopsy may be technically daunting given the immediately subjacent critical structures. There is a paucity of literature describing technique, safety, and efficacy. This study aims to quantify the diagnostic yield and safety of image-guided sternal biopsies. Secondary aims include (1) describing the preferred approach/technique and (2) identifying imaging features and disease entities associated with higher and lower diagnostic yields.
Materials and methods
A retrospective review of 50 image-guided sternal biopsies performed at two quaternary care centers from 2000 to 2019 was performed. Recorded lesion-related variables included as follows: location, density, extraosseous extension, and size. Recorded variables from electronic medical records included as follows: patient demographics, histologic or microbiological diagnosis, and complications. Recorded technique-related variables included as follows: needle obliquity, type, and gauge; biopsy core number and length; and modality.
Results
Of the 50 biopsies, 88.0% resulted in a definitive histologic diagnosis. Six biopsies were non-diagnostic. The majority of biopsies were performed under computed tomography (88.0%), followed by ultrasound (12.0%). Tumor was the most common biopsy indication (90.0%), followed by infection (10.0%). Of the diagnostic biopsies indicated for tumor, 88.9% were malignant. Seventy-four percent of the lesions were predominantly lytic. Fifty percent of lesions had extraosseous extension. Lesion locations were as follows: manubrium (48.0%), sternal body (48.0%), and sternomanubrial joint (4.0%). No minor or major, acute, or delayed procedure-related complications were encountered.
Conclusion
Image-guided sternal biopsy is an efficacious and safe method of obtaining a definitive histologic diagnosis regardless of lesion-specific features or location.
Similar content being viewed by others
References
Meek RD, Mills MK, Hanrahan CJ, et al. Pearls and pitfalls for soft-tissue and bone biopsies: a cross-institutional review. Radiographics. 2020;40(1):266–90.
Sung KS, Seo SW, Shon MS. The diagnostic value of needle biopsy for musculoskeletal lesions. Int Orthop. 2009;33(6):1701–6.
Choi JJ, Davis KW, Blankenbaker DG. Percutaneous musculoskeletal biopsy. Semin Roentgenol. 2004;39(1):114–28.
Espinosa LA, Jamadar DA, Jacobson JA, et al. CT-guided biopsy of bone: a radiologist’s perspective. AJR Am J Roentgenol. 2008;190(5):W283–9.
Welch BT, Welch TJ. Percutaneous image-guided biopsy of the musculoskeletal system. Tech Vasc Interv Radiol. 2011;14(3):110–7.
Song Y, Kwon JW. Percutaneous CT-guided sternal biopsy: factors affecting the diagnostic yield. Acta Radiol. 2017;58(7):825–33.
Rimondi E, Rossi G, Bartalena T, et al. Percutaneous CT-guided biopsy of the musculoskeletal system: results of 2027 cases. Eur J Radiol. 2011;77(1):34–42.
Restrepo CS, Martinez S, Lemos DF, et al. Imaging appearances of the sternum and sternoclavicular joints. Radiographics. 2009;29(3):839–59.
Shin MS, Berland LL, Ho KJ. Computed tomography evaluation of primary and secondary sternal neoplasms. J Comput Tomogr. 1986;10(1):27–32.
Downey RJ, Huvos AG, Martini N. Primary and secondary malignancies of the sternum. Semin Thorac Cardiovasc Surg. 1999;11(3):293–6.
Incarbone M, Nava M, Lequaglie C, Ravasi G, Pastorino U. Sternal resection for primary or secondary tumors. J Thorac Cardiovasc Surg. 1997;114(1):93–9.
Chang CY, Huang AJ, Bredella MA, et al. Percutaneous CT-guided needle biopsies of musculoskeletal tumors: a 5-year analysis of non-diagnostic biopsies. Skelet Radiol. 2015;44(12):1795–803.
Didolkar MM, Anderson ME, Hochman MG, et al. Image guided core needle biopsy of musculoskeletal lesions: are nondiagnostic results clinically useful? Clin Orthop Relat Res. 2013;471(11):3601–9.
Omura MC, Motamedi K, UyBico S, Nelson SD, Seeger LL. Revisiting CT-guided percutaneous core needle biopsy of musculoskeletal lesions: contributors to biopsy success. AJR Am J Roentgenol. 2011;197(2):457–61.
Baffour FI, Moynagh MR, Eiken PW, et al. Effectiveness and safety of percutaneous CT-guided rib biopsy. J Vasc Interv Radiol. 2019;30(1):82–6.
Jakanani GC, Saifuddin A. Percutaneous image-guided needle biopsy of rib lesions: a retrospective study of diagnostic outcome in 51 cases. Skelet Radiol. 2013;42(1):85–90.
Tomasian A, Hillen TJ, Jennings JW. Percutaneous CT-guided skull biopsy: feasibility, safety, and diagnostic yield. Am J Neuroradiol. 2019;40(2):309–12.
Li N, Maresh G, Cretcher M et al A modern non-SQL approach to radiology-centric search engine design with clinical validation. ArXIV. July 2020:2007.02124
Khalilzadeh O, Baerlocher MO, Shyn PB, et al. Proposal of a new adverse event classification by the Society of Interventional Radiology Standards of Practice Committee. J Vasc Interv Radiol. 2017;28(10):1432–1437.e3.
Wu JS, Goldsmith JD, Horwich PJ, Shetty SK, Hochman MG. Bone and soft-tissue lesions: what factors affect diagnostic yield of image-guided core-needle biopsy? Radiology. 2008;248(3):962–70.
Hwang S, Lefkowitz RA, Landa J, et al. Percutaneous CT-guided bone biopsy: diagnosis of malignancy in lesions with initially indeterminate biopsy results and CT features associated with diagnostic or indeterminate results. Am J Roentgenol. 2011;197(6):1417–25.
Yang J, Frassica FJ, Fayad L, Clark DP, Weber KL. Analysis of nondiagnostic results after image-guided needle biopsies of musculoskeletal lesions. Clin Orthop Relat Res. 2010;468(11):3103–11.
Unni KK. Dahlin’s bone tumors: general aspects and data on 11,087 cases. Philadelphia: Lippincott-Raven; 1996.
Douglas YL, Meuzelaar KJ, Van Der Lei B, Pras B, Hoekstra HJ. Osteosarcoma of the sternum. Eur J Surg Oncol. 1997;23(1):90–1.
Burt M. Primary malignant tumors of the chest wall. The Memorial Sloan-Kettering Cancer Center experience. Chest Surg Clin N Am. 1994;4(1):137–54.
Wu JS, McMahon CJ, Lozano-Calderon S, Kung JW. Utility of repeat core needle biopsy of musculoskeletal lesions with initially nondiagnostic findings. Am J Roentgenol. 2017;208(3):609–16.
Said N, Chalian M, Fox MG, Nacey NC. Percutaneous image-guided bone biopsy of osteomyelitis in the foot and pelvis has a low impact on guiding antibiotics management: a retrospective analysis of 60 bone biopsies. Skelet Radiol. 2019;48(9):1385–91.
Eng J, Sabanathan S, Pradhan GN, Mearns AJ. Primary bony chest wall tumours. J R Coll Surg Edinb. 1990;35(1):44–7.
Kwai AH, Stomper PC, Kaplan WD. Clinical significance of isolated scintigraphic sternal lesions in patients with breast cancer. J Nucl Med Off Publ Soc Nucl Med. 1988;29(3):324–8.
Toussirot E, Gallinet E, Augé B, Voillat L, Wendling D. Anterior chest wall malignancies. A review of ten cases. Rev Rhum Engl Ed. 1998;65(6):397–405.
Ahmad U, Yang H, Sima C, et al. Resection of primary and secondary tumors of the sternum: an analysis of prognostic variables. In: Annals of Thoracic Surgery, vol. 100. USA: Elsevier; 2015. p. 215–22.
Lee AY, Navarro R, Busby LP, et al. Characterization of metastatic sternal lesions on dynamic contrast-enhanced breast MRI in women with invasive breast cancer. Acad Radiol. 2019;26(10):1358–62.
Acknowledgments
We give our most sincere thanks to Dr. Ningcheng (Peter) Li, Dr. Judy Gichoya, and Guy Maresh for their development and continuous support of the OHSU Radiology Search Engine.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The study received approval from the institutional review board.
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Li, N.(., Wingfield, M.A., Mills, M.K. et al. Percutaneous image-guided sternal biopsy: a cross-institutional retrospective review of diagnostic yield and safety in 50 cases. Skeletal Radiol 50, 495–504 (2021). https://doi.org/10.1007/s00256-020-03587-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00256-020-03587-6